InvestorsHub Logo
Followers 827
Posts 119503
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Tuesday, 12/13/2022 11:03:36 AM

Tuesday, December 13, 2022 11:03:36 AM

Post# of 245
AEON Biopharma goes public via SPAC merger with PMGM:

https://www.globenewswire.com/news-release/2022/12/13/2572545/0/en/AEON-Biopharma-to-Become-Publicly-Listed-via-Merger-with-Priveterra-Acquisition-Corp-Accelerating-Clinical-Development-of-ABP-450-prabotulinumtoxinA-Injection-to-Treat-Debilitating.html

AEON is the former parent company of EOLS, which sells Jeuveau botulinum toxin for aesthetic indications. AEON’s ABP-450 is the same drug as Jeuveau, but AEON is seeking approval in therapeutic indications only, starting with cervical dystonia.

Daewoong of Korea is the toxin supplier for both EOLS and AEON.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News